XML 271 R59.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Components of share-based compensation expense, net of forfeitures
The components of the Company’s share-based compensation expense, net of forfeitures, were as follows:
Years Ended December 31,
2024
2023
2022
(in millions)
Stock option$15 $16 $16 
Restricted stock25 27 27 
Restricted stock units and deferred share units
153 144 127 
Liability awards58 62 44 
Total$251 $249 $214 
Weighted average assumptions used for stock option grants
The following weighted average assumptions were used for stock option grants:
2024
2023
2022
Dividend yield1.8 %2.0 %2.0 %
Expected volatility31 %33 %35 %
Risk-free interest rate4.0 %3.6 %1.7 %
Expected life of stock option (years)5.05.05.0
Summary of stock option activity
A summary of the Company’s stock option activity for 2024 is presented below (shares and intrinsic value in millions):
SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual
Term (Years)
Aggregate Intrinsic Value
Outstanding at January 12.3 $177.60 5$457 
Granted0.1 391.40 
Exercised(0.8)153.35 
Outstanding at December 311.6 207.11 5515 
Exercisable at December 311.3 173.69 5464 
Summary of activity for restricted stock, restricted stock units and stock and deferred share units
A summary of activity for the Company’s restricted stock awards, restricted stock units granted to employees (including advisors), compensation and commission deferrals into stock and deferred share units for 2024 is presented below (shares in millions):
SharesWeighted Average Grant-date
Fair Value
Non-vested shares at January 11.3 $250.16 
Granted0.3 405.99 
Deferred0.1 447.19 
Vested(0.6)283.08 
Forfeited— 321.45 
Non-vested shares at December 311.1 295.92